TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 243 filers reported holding TG THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $656,695 | -45.1% | 78,552 | +63.0% | 0.01% | -33.3% |
Q2 2023 | $1,196,866 | +14.4% | 48,183 | -30.8% | 0.01% | 0.0% |
Q1 2023 | $1,046,573 | -1.4% | 69,586 | -37.7% | 0.01% | +50.0% |
Q1 2022 | $1,061,000 | -36.2% | 111,655 | +27.5% | 0.01% | -33.3% |
Q4 2021 | $1,664,000 | -22.2% | 87,579 | +36.3% | 0.01% | -30.8% |
Q3 2021 | $2,138,000 | -4.3% | 64,243 | +11.5% | 0.01% | 0.0% |
Q2 2021 | $2,235,000 | -10.9% | 57,620 | +10.7% | 0.01% | -18.8% |
Q1 2021 | $2,508,000 | +135.7% | 52,036 | -30.6% | 0.02% | +433.3% |
Q1 2018 | $1,064,000 | -14.2% | 74,974 | -50.5% | 0.00% | 0.0% |
Q4 2017 | $1,240,000 | +2.7% | 151,387 | +48.5% | 0.00% | 0.0% |
Q3 2017 | $1,207,000 | +18.2% | 101,935 | +0.2% | 0.00% | 0.0% |
Q2 2017 | $1,021,000 | -21.7% | 101,723 | -9.1% | 0.00% | -25.0% |
Q1 2017 | $1,304,000 | +4.7% | 111,923 | -58.2% | 0.00% | 0.0% |
Q4 2016 | $1,246,000 | +0.6% | 267,985 | +67.6% | 0.00% | 0.0% |
Q3 2016 | $1,238,000 | +24.4% | 159,879 | -2.6% | 0.00% | +33.3% |
Q2 2016 | $995,000 | -2.7% | 164,213 | +36.8% | 0.00% | 0.0% |
Q1 2016 | $1,023,000 | -25.4% | 120,021 | +4.4% | 0.00% | -25.0% |
Q4 2015 | $1,372,000 | +15.0% | 114,924 | -2.9% | 0.00% | 0.0% |
Q3 2015 | $1,193,000 | – | 118,354 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 2,813,779 | $33,568,000 | 3.32% |
Opaleye Management Inc. | 300,000 | $3,579,000 | 1.50% |
BRIDGER MANAGEMENT, LLC | 3,068,315 | $36,605,000 | 1.21% |
SECTORAL ASSET MANAGEMENT INC | 1,521,667 | $18,153,000 | 0.77% |
STONERIDGE INVESTMENT PARTNERS LLC | 332,576 | $3,968,000 | 0.53% |
Eventide Asset Management | 537,600 | $6,414,000 | 0.32% |
Baker Brothers Advisors | 2,003,991 | $23,908,000 | 0.20% |
Quantitative Systematic Strategies LLC | 25,270 | $302,000 | 0.08% |
Candriam S.C.A. | 236,200 | $2,818,000 | 0.08% |
COLUMBUS CIRCLE INVESTORS | 705,389 | $8,415,000 | 0.07% |